Rapilazole may be available in the countries listed below.
Ingredient matches for Rapilazole
Lansoprazole
Lansoprazole is reported as an ingredient of Rapilazole in the following countries:
- Poland
International Drug Name Search
Sunday, 27 March 2011
Gludex
Gludex may be available in the countries listed below.
Ingredient matches for Gludex
Rosiglitazone
Rosiglitazone maleate (a derivative of Rosiglitazone) is reported as an ingredient of Gludex in the following countries:
- Argentina
International Drug Name Search
Thursday, 24 March 2011
Hartz
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Hartz
Methoprene
Methoprene is reported as an ingredient of Hartz in the following countries:
- United States
International Drug Name Search
Monday, 21 March 2011
Pancuronium-ratiopharm
Pancuronium-ratiopharm may be available in the countries listed below.
Ingredient matches for Pancuronium-ratiopharm
Pancuronium
Pancuronium Bromide is reported as an ingredient of Pancuronium-ratiopharm in the following countries:
- Germany
International Drug Name Search
Saturday, 19 March 2011
Famocid
Famocid may be available in the countries listed below.
Ingredient matches for Famocid
Famotidine
Famotidine is reported as an ingredient of Famocid in the following countries:
- Bahrain
- Hong Kong
- India
- Indonesia
- Myanmar
- Oman
- Sri Lanka
International Drug Name Search
Thursday, 17 March 2011
Estramustina Filaxis
Estramustina Filaxis may be available in the countries listed below.
Ingredient matches for Estramustina Filaxis
Estramustine
Estramustine 17ß-(disodium phosphate) (a derivative of Estramustine) is reported as an ingredient of Estramustina Filaxis in the following countries:
- Argentina
International Drug Name Search
Tuesday, 15 March 2011
Benzoyl Peroxide Foam
BENZOYL PEROXIDE 9.8% SHORT CONTACT FOAM
FOR EXTERNAL USE ONLY
Rx Only
Benzoyl Peroxide Foam Description
Each gram of Benzoyl Peroxide Short Contact Foam contains 9.8% benzoyl peroxide in an aqueous based emollient foam vehicle containing BHT, C12-15 alkyl benzoate, cetearyl alcohol, citric acid, dimethicone, disodium EDTA, emulsifying wax, glycerin, methylparaben, propylene glycol, propylparaben, purified water, sodium citrate, steareth-10. Also contains: Propellant HFA-134a (1,1,1,2-tetrafluoroethane).
Benzoyl peroxide is an oxidizing agent that possesses antibacterial properties and is classified as a keratolytic. Benzoyl peroxide (C14H10O4) is represented by the following structure:
Benzoyl Peroxide Foam - Clinical Pharmacology
The exact method of action of benzoyl peroxide in acne vulgaris is not known. Benzoyl peroxide is an antibacterial agent with demonstrated activity against Propionibacterium acnes. This action, combined with the mild keratolytic effect of benzoyl peroxide, is believed to be responsible for its usefulness in acne. Benzoyl peroxide is absorbed by the skin where it is metabolized to benzoic acid and excreted as benzoate in the urine.
Indications and Usage for Benzoyl Peroxide Foam
Benzoyl Peroxide Short Contact Foam is indicated for use in the topical treatment of mild to moderate acne vulgaris.
Contraindications
Benzoyl Peroxide Short Contact Foam should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the product. Discontinue use if hypersensitivity is observed.
Warnings
FOR EXTERNAL USE ONLY. Not for ophthalmic use. Keep out of the reach of children.
When using this product, skin irritation and dryness is more likely to occur if:
- you leave Benzoyl Peroxide Short Contact Foam on your skin longer than directed
- you use another topical acne medication at the same time
If irritation occurs:
- use Benzoyl Peroxide Short Contact Foam less frequently
- use one topical acne medication at a time
- stop use and ask a doctor if irritation becomes severe
Do not use if you:
- have very sensitive skin
- are sensitive to benzoyl peroxide
When using this product:
- avoid unnecessary sun exposure and use a sunscreen
- avoid contact with the eyes, lips, and mouth
- avoid contact with hair and dyed fabrics, which may be bleached by this product
- skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling
Contents under pressure. Do not puncture or incinerate container. Do not expose to temperature above 120°F (49°C).
Precautions
General:
If severe irritation develops, discontinue use and institute appropriate therapy.
Information for Patients:
This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. Avoid contact with eyes, eyelids, lips, and mucous membranes. If accidental contact occurs, rinse with water. If excessive redness or irritation develops, discontinue use and consult your physician.
Carcinogenesis, Mutagenesis, Impairment of Fertility:
Based upon all available evidence, benzoyl peroxide is not considered to be a carcinogen. However, data from a study using mice known to be highly susceptible to cancer suggest that benzoyl peroxide acts as a tumor promoter. The clinical significance of the findings is not known.
Pregnancy:
Category C. Animal reproduction studies have not been conducted with benzoyl peroxide. It is also not known whether benzoyl peroxide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzoyl peroxide should be used by a pregnant woman only if clearly needed.
Nursing Mothers:
It is not known whether this drug is excreted in the human milk. Because many drugs are excreted in human milk, caution should be exercised when benzoyl peroxide is administered to a nursing woman.
Pediatric Use:
Safety and effectiveness in children below the age of 12 have not been established.
Adverse Reactions
Allergic contact dermatitis and dryness have been reported with topical benzoyl peroxide therapy.
Overdosage
If excessive scaling, erythema or edema occurs, the use of this preparation should be discontinued. To hasten resolution of the adverse effects, cool compresses may be used. After symptoms and signs subside, a reduced dosage schedule may be cautiously tried if the reaction is judged to be due to excessive use and not allergenicity.
Benzoyl Peroxide Foam Dosage and Administration
- Avoid contact with hair, fabrics or carpeting as benzoyl peroxide may cause bleaching or discoloration.
Prime Can Before Initial Use: Gently push up on actuator with thumb until tab breaks. Shake can vigorously (until product moves inside can). Firmly strike bottom of can onto palm of other hand or a hard surface at least 3 times. Holding can upright over sink, direct initial spray to a non-skin surface. Until primed, DO NOT spray directly on the skin as the initial spray may expel cold liquid propellant. Press down on actuator for 1-3 seconds until foam begins to dispense. If foam does not dispense within 3 seconds, prime can again.
Before Each Use: Shake can vigorously. Firmly strike bottom of can onto palm of other hand or a hard surface at least 3 times.
During Use: Holding can upright, dispense Benzoyl Peroxide Short Contact Foam into palm of hand. Cover the entire affected area with a thin layer 1 to 3 times daily. Rub in until completely absorbed. Rinse off after 2 minutes. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day. Wash hands with soap and water after use. If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.
HOW SUPPLIED:
Benzoyl Peroxide Short Contact Foam is supplied in 100g (NDC 49808-201-96) aluminum cans. Will not dispense entire contents. Container is overfilled to guarantee dispensing at least the listed amount.
Store at room temperature: 59º - 77ºF (15º - 25ºC).
Protect from freezing. Store upright.
Manufactured in USA For:
Metacon Labs
866-777-4633
www.metaconlabs.com
PATENT PENDING
P/N 2622 Rev. 0
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - Benzoyl Peroxide Short Contact Foam 100 grams Can Label
Rx Only
Benzoyl Peroxide 9.8%
Short Contact Foam
NDC 49808-201-96
Net Weight 100g
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - Benzoyl Peroxide Short Contact Foam 100 grams Carton Label
Rx Only
Benzoyl Peroxide 9.8%
Short Contact Foam
NDC 49808-201-96
Net Weight 100g
| BENZOYL PEROXIDE SHORT CONTACT benzoyl peroxide aerosol, foam | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph final | part333D | 04/01/2011 | |
| Labeler - Metacon Labs (793223707) |
| Registrant - Onset Dermatologics LLC (793223707) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Metacon Labs | 793223707 | MANUFACTURE | |
More Benzoyl Peroxide Foam resources
- Benzoyl Peroxide Foam Side Effects (in more detail)
- Benzoyl Peroxide Foam Use in Pregnancy & Breastfeeding
- Benzoyl Peroxide Foam Drug Interactions
- Benzoyl Peroxide Foam Support Group
- 15 Reviews for Benzoyl Peroxide - Add your own review/rating
Compare Benzoyl Peroxide Foam with other medications
- Acne
- Perioral Dermatitis
Monday, 7 March 2011
Somno
Somno may be available in the countries listed below.
Ingredient matches for Somno
Zolpidem
Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Somno in the following countries:
- Chile
- Peru
International Drug Name Search
Subscribe to:
Comments (Atom)